disease 1,504 words KG: ent-dise-9b2d6832 2026-03-24
kind:diseasesection:diseasesstate:published
Contents

Nasu-Hakola Disease (PLOSL)

Disease Info
Cognitive declineProgressive presenile dementia resembling Alzheimer's Disease
Behavioral changesFrontal lobe syndrome with personality alterations, loss of social inhibitions, aggressive behavior
Mood disturbancesEuphoria, apathy, depression
Speech disordersDysarthria, eventual mutism
Motor symptomsUpper motor neuron signs including spasticity, myoclonus, gait disturbance
SeizuresGeneralized tonic-clonic seizures
Agnosia and apraxiaLoss of sensory and motor planning abilities
Memory impairmentProgressive forgetfulness and cognitive deficits
DatabasesOMIMOrphanetClinicalTrialsPubMed

Knowledge Graph

Related Hypotheses (9)

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR
Score: 0.45
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41

Related Analyses (19)

Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Related Experiments (3)

Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40